Medical Oncology

Guest Editorial
pp. S01-S02(2)
Authors: Michael Keating; Michael Hallek

A Personal History of the CAMPATH-1H Antibody
pp. S03-S10(8)
Author: Herman Waldmann

Current and Developing Chemotherapy for CLL
pp. S11-S20(10)
Author: Emili Montserrat

Clinical Effects of Alemtuzumab (Campath-1H) in B-cell Chronic Lymphocytic Leukemia
pp. S21-S26(6)
Authors: Anders Osterborg; Hakan Mellstedt; Michael Keating

Alemtuzumab in T-Cell Malignancies
pp. S27-S32(6)
Authors: Claire E. Dearden; Estella Matutes; Daniel Catovsky

Alemtuzumab in Stem Cell Transplantation
pp. S33-S48(16)
Author: Geoff Hale

Immunological Effects and Safe Administration of Alemtuzumab (MabCampath™) in Advanced B-CLL
pp. S49-S56(8)
Authors: Peter Hillmen; Ben Kennedy

Future Prospects for Alemtuzumab (MabCampath™)
pp. S57-S64(8)
Authors: Kanti Rai; Michael Hallek